Ascent Group, LLC Dexcom Inc Transaction History

Ascent Group, LLC

$1.29 Billion
Q3 2024

A detailed history of Ascent Group, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Ascent Group, LLC holds 7,950 shares of DXCM stock, worth $705,801. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,950

Previous 7,367 7.91%

Holding current value

$705,801

Previous $835,000 36.29%

% of portfolio

0.04%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $37,312 - $67,662	583 Added 7.91%	7,950 $532,000
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $118,252 - $150,562	1,072 Added 17.03%	7,367 $835,000
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $25,356 - $31,102	222 Added 3.66%	6,295 $873,000
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $79,038 - $129,995	1,047 Added 20.83%	6,073 $753,000
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $6,110 - $9,793	71 Added 1.43%	5,026 $468,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $165,780 - $193,064	-1,474 Reduced 22.93%	4,955 $636,000
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $159,120 - $188,067	1,530 Added 31.23%	6,429 $746,000
Q4 2022 Feb 16, 2023	BUY	$84.98 - $122.67 $10,282 - $14,843	121 Added 2.53%	4,899 $554,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $7,482 - $9,229	98 Added 2.09%	4,778 $577,000
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $244,831 - $478,536	3,601 Added 333.73%	4,680 $384,000
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $13,735 - $19,009	146 Added 15.65%	1,079 $552,000
Q4 2021 Mar 01, 2022	BUY	$129.87 - $162.82 $121,168 - $151,911	933 New	933 $394,000

Others Institutions Holding DXCM

# of Institutions

1,035

Shares Held

353M

Call Options Held

5.51M

Put Options Held

5.61M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account